CART
Live / Registered — Registered (as of 07 Nov 2023)
What this means for you
Registered since 07 Nov 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97260865
- Registration number
- 7210199
- Mark type
- Stylized text
- Filed
- 10 Feb 2022
- Published for opposition
- 22 Aug 2023
- Registered
- 07 Nov 2023
- Attorney of record
- John Paul Oleksiuk
Goods and services
- Class 005 — Pharmaceuticals: Gene therapy products, namely, biopharmaceutical preparations primarily composed of adeno-associated virus (AAV) vectors comprising of a transgene or other nucleic acid payload for delivery to a cell or tissue; biopharmaceutical preparations, namely, biopharmaceutical preparations primarily composed of adeno-associated virus (AAV) vectors comprising a transgene or other nucleic acid payload for delivery to a cell or tissue; biological preparations; therapeutic biopharmaceutical products for medical and clinical gene therapy; all of the above for the treatment of genetic diseases, conditions and disorders primarily related to the muscle or central nervous system
- Class 042 — Scientific and technological services: Scientific and medical research and development services in the field of treatment of rare genetic diseases, conditions and disorders primarily related to the muscle or central nervous system
Owner
- Affinia Therapeutics Inc., Waltham, MA, US
- Affinia Therapeutics Inc., Waltham, MA, US
- Affinia Therapeutics Inc., Waltham, MA, US
Prosecution history
- 07 Nov 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 07 Nov 2023 — REGISTERED-PRINCIPAL REGISTER
- 22 Aug 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 22 Aug 2023 — PUBLISHED FOR OPPOSITION
- 02 Aug 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 14 Jul 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 12 Jul 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 12 Jul 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 12 Jul 2023 — ASSIGNED TO LIE
- 10 Mar 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 26 Nov 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 26 Nov 2022 — NON-FINAL ACTION E-MAILED
- 26 Nov 2022 — NON-FINAL ACTION WRITTEN
- 26 Nov 2022 — ASSIGNED TO EXAMINER
- 15 Feb 2022 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED